{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:01:28Z","timestamp":1770454888035,"version":"3.49.0"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.01160","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T16:29:56Z","timestamp":1594398596000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option"],"prefix":"10.3389","volume":"10","author":[{"given":"Hyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pil Soo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Sun","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sungwoo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Hyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1056\/NEJMoa0912614","article-title":"Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia","volume":"362","author":"Saglio","year":"2010","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11899-016-0309-2","article-title":"Long-term side effects of tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"11","author":"Caldemeyer","year":"2016","journal-title":"Curr Hematol Malig Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.14309\/crj.0000000000000003","article-title":"A case of severe, nilotinib-Induced liver injury","volume":"6","author":"Belopolsky","year":"2019","journal-title":"ACG Case Rep J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3350\/cmh.2019.1003","article-title":"Drug induced liver injury: east versus west - a systematic review and meta-analysis","volume":"26","author":"Low","year":"2019","journal-title":"Clin Mol Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"EASL clinical practice guidelines: drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"10","author":"Mack","year":"2019","journal-title":"Hepatology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cotox.2017.12.006","article-title":"Immune drug-induced liver disease and drugs","volume":"10","author":"Waddington","year":"2018","journal-title":"Curr Opin Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/cei.12558","article-title":"Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis","volume":"180","author":"Foureau","year":"2015","journal-title":"Clin Exp Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.immuni.2017.11.025","article-title":"Innate-like cytotoxic function of bystander-Activated cD8(+) t cells is associated with liver injury in acute hepatitis a","volume":"48","author":"Kim","year":"2018","journal-title":"Immunity."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0316-1","article-title":"The activation of bystander cD8(+) t cells and their roles in viral infection","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01160\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T16:29:58Z","timestamp":1594398598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.01160\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":10,"alternative-id":["10.3389\/fonc.2020.01160"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.01160","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"article-number":"1160"}}